Insulet (NASDAQ:PODD) Upgraded at Robert W. Baird

Insulet (NASDAQ:PODD – Get Free Report) was upgraded by equities researchers at Robert W. Baird from a “neutral” rating to an “outperform” rating in a research report issued to clients and investors on Thursday, Marketbeat reports. The firm presently has a $238.00 price objective on the medical instruments supplier’s stock, up from their previous price […]

Related Keywords

United States ,America ,Robertw Baird ,Raymond James ,Shacey Petrovic ,Insulet Corporation ,William Blair Investment Management ,Geode Capital Management ,Jefferies Financial Group ,Moneta Group Investment Advisors ,Clearbridge Investments ,Insulet Company Profile ,Vanguard Group Inc ,Get Free Report ,Financial Group ,Trading Down ,Director Shacey Petrovic ,Capital Management ,Group Investment Advisors ,Blair Investment Management ,Omnipod System ,Insulet Daily ,Insulet ,Nasdaq Podd ,Podd ,Medical ,45784p10 ,Upgrade ,